| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |